Back
First Trust S&P 500 Diversified Dv Aristocrats ETF Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
54
KNGZ
First Trust S&P 500 Diversified Dv Aristocrats ETF
Last Price:
$35.88
Seasonality Move:
3.37%
Sell
46
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$61.04
Seasonality Move:
-2.16%
Buy
54
First Trust S&P 500 Diversified Dv Aristocrats ETF (KNGZ)
is a Buy
Is First Trust S&P 500 Diversified Dv Aristocrats ETF a Buy, Sell or Hold?
-
The current First Trust S&P 500 Diversified Dv Aristocrats ETF [KNGZ] share price is $36.14. The Score for KNGZ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
KNGZ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $61.03. The Score for ARWR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNGZ Stock Price Chart
What is First Trust S&P 500 Diversified Dv Aristocrats ETF's stock price today?
-
The First Trust S&P 500 Diversified Dv Aristocrats ETF share price today is $36.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNGZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $61.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing selling pressure, which indicates risk of future bearish movement.
KNGZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 46.22 | Sell |
| Chaikin Money Flow: | 871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.59 - 37.29) | Sell |
| Bollinger Bands (100): | (35.39 - 37.77) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | -832975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.52 - 62.66) | Buy |
| Bollinger Bands (100): | (52.16 - 69.78) | Buy |
KNGZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.9 | Buy |
| 20-day SMA: | 36.07 | Buy |
| 50-day SMA: | 37.23 | Sell |
| 200-day SMA: | 35.7 | Buy |
| 8-day EMA: | 35.93 | Buy |
| 20-day EMA: | 36.22 | Sell |
| 50-day EMA: | 36.68 | Sell |
| 200-day EMA: | 35.71 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.99 | Buy |
| 20-day SMA: | 58.47 | Buy |
| 50-day SMA: | 62.54 | Sell |
| 200-day SMA: | 43.35 | Buy |
| 8-day EMA: | 60.24 | Buy |
| 20-day EMA: | 59.83 | Buy |
| 50-day EMA: | 60.7 | Buy |
| 200-day EMA: | 47.94 | Buy |
First Trust S&P 500 Diversified Dv Aristocrats ETF Earnings Growth & KNGZ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.10 per share, a decrease this year of $3.21 per share, and a decrease next year of $1.06 per share.
First Trust S&P 500 Diversified Dv Aristocrats ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||